IRB Advisor – May 1, 2005
May 1, 2005
View Issues
-
Prop 71 opens doors to stem cell research; IRBs look for guidance
More IRBs are being drawn into the complex and controversial world of human embryonic stem cell research. -
CALBIO summit considers implications of Prop. 71
Individual states, including California, Illinois, Massachusetts, New Jersey, New York, and Wisconsin, now are moving forward to fill the funding gap for stem cell research. So far, California leads the pack voters approved a $3 billion bond measure for stem cell research in November. -
Hospital’s e-learning tool teaches informed consent
The Medical College of Wisconsin is enlisting technology in the task of teaching investigators and research participants about the importance of obtaining truly informed consent in clinical research. -
Review warning letters to prepare for audits
A survey of warning letters sent to IRBs by the FDA shows that most of the offenders were deficient in some of the most fundamental areas of responsibility failing to have or follow adequate review procedures and failure to maintain adequate documentation of IRB activities. -
Look to support groups for community members
Support groups for people who suffer from chronic or life-threatening illnesses can be a valuable source of community members for IRBs, says a woman who founded a support group and serves on two boards. -
Few minorities enroll in clinical trials
Mistrust of the medical and science communities may be discouraging non-Caucasian cancer patients from enrolling in clinical trials, a research group has discovered. -
News Briefs
The federal Office for Human Research Protections (OHRP) is seeking public comment through May 24 on recommendations regarding the use of human subjects protection procedures of foreign countries in overseas research.